Skip to main content

BARCLAYS PLC

Position in BEAM — Beam Therapeutics Inc.

CIK 312069 LONDON, X0

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,409,915
+$1,274,703 QoQ
Shares Held
70,219
+47.4% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 274 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Derivatives in BEAM

reported options exposure · as of Sep 30, 2024
CallValue
$735,000
CallShares
30,000
PutValue
$735,000
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. BEAM ranks #63 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,409,915 70,219
2026-03-31 $1,135,212 47,638
2025-12-31 $9,041,653 326,178
2025-09-30 $7,611,725 313,627
2025-06-30 $11,645,027 684,599
2025-03-31 $3,125,697 160,046
2024-12-31 $6,894,871 278,019
2024-09-30 $735,000 30,000
2024-09-30 $735,000 30,000
2024-09-30 $4,488,742 183,214
2024-06-30 $1,030,920 44,000
2024-06-30 $1,917,205 81,827
2024-03-31 $1,552,880 47,000
2024-03-31 $2,863,774 86,676
2024-03-31 $1,552,880 47,000
2023-12-31 $6,761,012 248,384
2023-09-30 $4,753,410 197,647
2023-06-30 $4,614,906 144,532
2023-03-31 $3,540,559 115,629
2022-12-31 $4,756,518 121,619
2022-09-30 $5,180,182 108,736
2022-06-30 $1,179,454 30,469
2022-03-31 $860,932 15,025